Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: A comprehensive analysis of pattern of postoperative complications

Annals of Surgical Oncology

Volumn 21, Issue 5, 2014, Pages 1692-1699

  Ferrandina, Gabriella ^a   Ercoli, Alfredo ^b   Fagotti, Anna ^c   Fanfani, Francesco ^d   Gallotta, Valerio ^a   Margariti, Alessandro P ^a   Salerno, Maria Giovanna ^e   Chiantera, Vito ^f   Legge, Francesco ^f   Macchia, Gabriella ^g   Morganti, Alessio G ^g   Valentini, Vincenzo ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Gynecologic Oncology Unit Policlinico Abano Terme   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g Giovanni Paolo II Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ABDOMINAL INJURY; ACUTE KIDNEY FAILURE; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER DYSFUNCTION; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL EXAMINATION; COLON OBSTRUCTION; CONTINUOUS INFUSION; CYSTOSCOPY; CYSTOVAGINAL FISTULA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; INTESTINE PERFORATION; KAPLAN MEIER METHOD; KIDNEY FUNCTION; LAPAROTOMY; LEG EDEMA; LOCALLY ADVANCED CERVICAL CANCER; LUNG EDEMA; LYMPH NODE DISSECTION; LYMPHOCELE; MAJOR CLINICAL STUDY; MORBIDITY; NEPHROSTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS ABSCESS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADICAL HYSTERECTOMY; RECTOSCOPY; SEPTICEMIA; SURGICAL RISK; THORAX RADIOGRAPHY; THROMBOPHLEBITIS; TREATMENT RESPONSE; URETER DILATATION; URETER OBSTRUCTION; URETEROVAGINAL FISTULA; URINE INCONTINENCE; URINE RETENTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VAGINA DISEASE; WOUND DEHISCENCE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER GRADING; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; HYSTERECTOMY; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM GRADING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84898881212     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3471-y     Document Type: Article

References (30)

1. McNeil C. New standard of care for cervical cancer sets stage for next questions. J Natl Cancer Inst. 1999;91:500-1.
2. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). Reducing uncertainties about the effect of chemoradiotherapy for cervical cancer: individual patients data meta-analysis. Cochrane Database Syst Rev. 2010;CD008285.
3. Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, et al. and Groupe des Chirurgiens de Centre de Lutte Contre le Cancer, Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006;102:523-9. (Pubitemid 44353647)
4. Ferrandina G, Margariti PA, Smaniotto D, Petrillo M, Salerno MG, Fagotti A, et al. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol. 2010;119:404-10.
5. Motton S, Houvenaeghel G, Delannes M, Querleu D, Soulé-Tholy M, Hoff J, et al. Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy. Int J Gynecol Cancer. 2010;20:268-75.
6. Touboul C, Uzan C, Mauguen A, Gouy S, Rey A, Pautier P, et al. Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 2010;15:405-15.
7. Leguevaque P, Motton S, Delannes M, Querleu D, Soule-Tholy M, Tap G, et al. Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer? Eur J Obstet Gynecol Rep Biol 2011;155:188-92.
8. Morice P, Uzan C, Zafrani Y, Delpech Y, Gouy S, Haie-Meder C. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer. Gynecol Oncol. 2007;107:S122-4. (Pubitemid 47483860)
9. Keys HM, Bundy BN, Stehman FB, Okagaki T, Gallup DG, Burnett AF, et al. Gynecologic Oncology Group. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003;89:343-53. (Pubitemid 36687776)
10. Morice P, Rouanet P, Rey A, Romestaing P, Houvenaeghel G, Boulanger JC, et al. Results of the GYNECO 02 study, an FNCLCC Phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB or II cervical cancer. Oncologist. 2012;17:64-71.
11. Guth U, Hadwin RJ, Schotzau A, McCormack M. Clinical outcomes and patterns of severe late toxicity in the era of chemo-radiation for cervical cancer. Arch Gynecol Obstet. 2012;285:1703-11.
12. Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: An inter-era analysis. Int J Radiat Oncol Biol Phys. 2012;84:973-82.
13. Tan LT, Zahara M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer. The Addenbrooke's experience. Clin Oncol. 2008;20:358-64.
14. Houvenaeghel G, Lelievre L, Rigouard AL, Buttarelli M, Jacquemier J, Viens P, et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol. 2006;102:74-9. (Pubitemid 43851056)
15. Cellini N, Smaniotto D, Scambia G, Luzi S, Balducci M, Ferrandina G, et al. Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: A dose-escalation study. Am J Clin Oncol. 2008;31:280-4.
16. Macchia G, Ferrandina G, Legge F, Deodato F, Ruggieri V, Lorusso D, et al. Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). Am J Clin Oncol. 2010;33:577-82.
17. Macchia G, Morganti AG, Deodato F, Cilla S, Lucidi A, Massaccesi M, et al. Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1). Gynecol Oncol. 2012;125:594-9.
18. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-16.
19. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer, Obstet Gynecol. 1974;44:265-72.
20. Chassagne D, Sismondi P, Horiot JC, Sinistrero G, Bey P, Zola P, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol. 1993;26:195-202. (Pubitemid 23132287)
21. Cox DR. Analysis of binary data. London: Methuen. 1970.
22. Kaplan FL, Meier P. Non parametric estimation from incomplete observations. Am J Stat Assoc. 1958;53:457-81.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-70.
24. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34:197-220.
25. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al., Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-80. (Pubitemid 41103599)
26. Ferrandina G, Lucidi A, Paglia A, Corrado G, Macchia G, Tagliaferri L, et al. Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications. Eur J Surg Oncol. 2012;38:238-44.
27. Fanfani F, Fagotti A, Gagliardi G, Gallotta V, Zannoni GF, Scambia G. Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation. Eur J Surg Oncol. 2013:39:1025-9.
28. Ferrandina G, Legge F, Fagotti A, Fanfani F, Distefano M, Morganti A, et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecol Oncol. 2007;107:S127-32. (Pubitemid 47483852)
29. Colombo PE, Bertrand MM, Gutowski M, Mourregot A, Fabbro M, Saint-Aubert B, et al. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results. Gynecol Oncol. 2009;114:404-9.
30. Lambaudie E, Narducci F, Bannier M, Jauffret C, Pouget N, Leblanc E, et al. Role of robot-assisted laparoscopy in adjuvant surgery for locally advanced cervical cancer. Eur J Surg Oncol. 2010;36:409-13.